Get these analyses to your inbox — https://axialfc.substack.com/ This is a newsletter for new financing events with some simple analysis. More well thought out work can be found at — https://axial.substack.com/
Axial invests and partners in early-stage life sciences companies. If you or someone you know has a great idea or company in life sciences, Axial would be excited to get to know you and possibly invest in your vision and company — info@axialsprawl.com
Life Sciences Financings and Commentary #7 — May 9, 2020 — May 15, 2020
Financings
Number of deals: 18 & Total capital invested: $340.4M
- BurnAlong raised $4M from CR2 Ventures and DM Wellness to commercialize their corporate wellness app focused on telemedicine. Despite the generic-style of the product, if the company can get the corporate contracts, that’s a pretty nice lock-in to get. There’s a lot of competition here and some really great products already on the market.
- Carbon Health raised $26M from DCVC to extend their Series B to help the company to extend its primary care product to COVID-19 treatment. Carbon is doing some great work building out mobile clinics to diagnose COVID-19. In general, the business is focused on unbundling primary, urgent, and now virtual care — a really tough task. Historically, focused digital health companies have been rewarded.
